Mucoadhesive Chitosan-Coated Cationic Microemulsion of Dexamethasone for Ocular Delivery: In Vitro and In Vivo Evaluation

References

• Ogura Y. Drug delivery to the posterior segments of the eye. Adv Drug Deliv Rev 2001;52:1–3
   PubMed Web of Science ®Google Scholar
• Ahmed I, Patton TF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 1985;26:584–587
   PubMed Web of Science ®Google Scholar
• Ahmed I, Patton TF. Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption. Int J Pharm 1987;38:9–21
   Web of Science ®Google Scholar
• Desai SD, Blanchard J. Ocular drug formulation and delivery. In: Swarbick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology. Vol. 11. New York: Marcel Dekker; 1994. pp. 43–75
   Google Scholar
• Felt O, Furrer P, Mayer JM, et al. Topical use of chitosan in ophthalmology: tolerance, assessment and evaluation of precorneal retention. Int J Pharm 1999;180:185–193
   PubMed Web of Science ®Google Scholar
• Kesavan K, Nath G, Pandit JK. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system. DARU 2010;18:237–246
   PubMed Web of Science ®Google Scholar
• Kesavan K, Nath G, Pandit JK. Sodium alginate based mucoadhesive system for gatifloxacin and its in vitro antibacterial activity. Sci Pharm 2010;78:941–957
   PubMedGoogle Scholar
• Kesavan K, Kant S, Singh PN, et al. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel. Curr Eye Res 2011;36:918–929
   PubMed Web of Science ®Google Scholar
• Bourlais CL, Acar L, Zia H, et al. Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res 1998;17:33–58
   PubMed Web of Science ®Google Scholar
• Vandamme Th.F. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002;21:15–34
   PubMed Web of Science ®Google Scholar
• Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 1999;16:461–521
   PubMed Web of Science ®Google Scholar
• Silva-Cunha A, Fialho SL, Carneiro LB, et al. Microemulsões como veículos de drogas para administração ocular tópica. Arq Bras Oftalmol 2003;66:385–391
   Google Scholar
• Durrani AM, Davies NM, Thomas M, et al. Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. Int J Pharm 1992;88:409–415
   Web of Science ®Google Scholar
• Davies NM, Farr SJ, Hadgraft J, et al. Evaluation of mucoadhesive polymers in ocular drug delivery: II. Polymer coated vesicles. Pharm Res 1992;9:1137–1144
   PubMed Web of Science ®Google Scholar
• Law SL, Huang KJ, Chiang CH. Acyclovir-containing liposomes for potential ocular delivery corneal penetration and absorption. J Control Release 2000;63:135–140
   PubMed Web of Science ®Google Scholar
• De Campos AM, Diebold Y, Carvalho ELS, et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004;21:803–810
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bowstra JA, Schacht EH, et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43–48
   Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 2011;16:44–56
   PubMed Web of Science ®Google Scholar
• Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 1988;9:28–31
   PubMedGoogle Scholar
• Li Q, Peng B, Whitcup SM, et al. Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res 1995;61:629–632
   PubMed Web of Science ®Google Scholar
• Gupta SK, Agarwal R, Srivastava S, et al. The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits. Invest Ophthalmol Vis Sci 2008;49:4036–4040
   PubMed Web of Science ®Google Scholar
• Munoz-Fernandez S, Martin-Mola E. Uveitis. Best Pract Res Clin Rheumatol 2006;20:487–505
   PubMed Web of Science ®Google Scholar
• Kristinsson JK, Fridriksdottir H, Thorisdottir S, et al. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops – aqueous humor pharmacokinetics in humans. Invest Ophthalmol Vis Sci 1996;7:1199–1203
   Google Scholar
• Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 1990;7:491–495
   PubMed Web of Science ®Google Scholar
• Ruiz-Moreno JM, Thillaye B, De Kozak Y. Retino-choroidal changes in endotoxin-induced uveitis in the rat. Ophthalmic Res 1992;24:162–168
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Yasueda S, Isowaki A, et al. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int J Pharm 2005;301:121–128
   PubMed Web of Science ®Google Scholar
• Alany RG, Tucker IG, Davies NM, et al. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 2001;27:31–38
   PubMed Web of Science ®Google Scholar
• Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifyingdrug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001;212:233–246
   PubMed Web of Science ®Google Scholar
• Grant WM, Schuman JS. Toxicology of the eye. 4th ed. Springfield: Charles C. Thomas; 1993
   Google Scholar
• Bietti GB, Virno M, Pecori-Giraldi J. Propylene glycol: a new osmotic agent for ophthalmic uses. Doc Ophthalmol 1973;34:77–92
   Google Scholar
• Liu D, Ma J, Cheng H, et al. Solubilization behavior of mixed reverse micelles: effect of surfactant component, electrolyte concentration and solvent. Colloids Surf A Physicochem Eng Asp 1998;143:59–68
   Google Scholar
• Leung R, Shah DO. Solubilization and phase equilibria of water-in-oil microemulsions: I. Effects of spontaneous curvature and elasticity of interfacial films. J Colloid Interface Sci 1987;120:320–329
   Web of Science ®Google Scholar
• Aboofazeli R, Lawrence MJ. Investigations into the formation and characterization of phospholipid microemulsions. I. Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristate. Int J Pharm 1993;93:161–175
   Web of Science ®Google Scholar
• Baker RC, Florence AT, Tadros ThF, et al. Investigations into the formation and characterization of microemulsions. I. Phase diagrams of the ternary system water–sodium alkyl benzene sulfonate–hexanol and the quaternary system water–xylene–sodium alkyl benzene sulfonate–hexanol. J Colloid Interface Sci 1984;100:311–331
   Web of Science ®Google Scholar
• Li L, Nandi I, Kim KH. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int J Pharm 2002;237:77– 85
   PubMed Web of Science ®Google Scholar
• Charman SA, Charman WN, Rogg MC, et al. Self-emulsifying systems formulation and biological evaluation of an investigative lipophilic compound. Pharm Res 1992;9:87–94
   PubMed Web of Science ®Google Scholar
• Fialho SL, Da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Experiment Ophthalmol 2004;32:626–632
   PubMed Web of Science ®Google Scholar
• Mathis GA. Clinical ophthalmic pharmacology: therapeutics: ocular drug delivery. In: Gelatt KN, Veterinary ophthalmology. Orlando: Lippincott Williams & Wilkins; 1999. pp. 291–297
   Google Scholar
• Van Ooteghem MM. Formulations of ophthalmic solutions and suspensions. Problems and advantages. In: Edman P, Biopharmaceutics of ocular drug delivery. Boca Raton: CRC; 1993. pp. 31–32
   Google Scholar
• Zignani M, Tabatabay C, Gurny R. Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels. Adv Drug Deliv Rev 1995;16:51–61
   Web of Science ®Google Scholar
• Vandamme ThF, Brobeck L. Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 2005;102:23–38
   PubMed Web of Science ®Google Scholar
• Lee PJ, Langer R, Shastri VP. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res 2003;20:264–269
   PubMed Web of Science ®Google Scholar